The Next Hot Commodity of Genome Sequences
Richard Resnick on the pros and cons of the increasing ease with which millions of human genomes are being sequenced and connected. While commoditizing gene sequences will save lives by identifying diseases, it also raises serious cultural and ethical concerns on sharing personal information.
Curator’s Pick: “Now think of it. It’s 2016 and the leading candidate releases not only her 4 years of back tax return, but also her personal genome. Do you think that’s not going to happen?”
About Richard: http://www.genomequest.com/company/management/
Resnick has led GenomeQuest’s products and services operations since 2008. He has extensive experience building and growing innovative technology companies in the life sciences. He was previously CEO of Mosaic Bioinformatics, which was sold to NetGenics. Prior to Mosaic, Resnick was global bioinformatics software head for Wyeth, and, before that, a member of the Human Genome Project under Eric Lander at MIT. Resnick holds an M.B.A. from the Sloan School at MIT, an M.S. in Computer Science from WPI, and a B.S. in Computer Science from UMass Amherst.